Colonic drug delivery can facilitate access to unique therapeutic targets and has the
potential to enhance drug bioavailability whilst reducing off-target effects. Delivering drugs to …

Colon-specific drug delivery systems (CDDS) are desirable for the treatment of a range of
local diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, chronic …

Targeted drug delivery to the colon offers a myriad of benefits, including treatment of local
diseases, direct access to unique therapeutic targets and the potential for increasing …

In the last two decades colon targeted drug delivery has gained increased importance not
just for the deliver drugs for the treatment of various colonic diseases but also for its potential …

Colon targeted drug delivery systems have gained a great deal of attention as potential
carriers for the local treatment of colonic diseases with reduced systemic side effects and …

Oral drug delivery to the colon has attracted significant attention during the past 20 years.
Colon targeting is recognised to have several therapeutic advantages, such as the oral …

The necessity and advantages of colon-specific drug delivery systems have been well
recognized and documented. In the past, the primary approaches to obtain colon-specific …

Nano-drug delivery systems (NDDS) for colon-targeted drug delivery are an active area of
research on local diseases affecting the colon, such as ulcerative colitis, Crohn's disease …

Oral colon-specific drug-delivery systems have recently gained importance for delivering a
variety of therapeutic agents. The major obstacles to delivering drugs to the colon are the …

The colon is a site where both local and systemic delivery of drugs can take place. Local
delivery allows topical treatment of inflammatory bowel disease. However, treatment can be …